CONMED CORPORATION Gain (Loss) on Sale of Properties
CONMED CORPORATION (CNMD) reported Gain (Loss) on Sale of Properties of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-25.
Discontinued › Cash Flow › Operating Activities
us-gaap:GainLossOnSaleOfProperties · last filed 2019-02-25
- CONMED CORPORATION gain (loss) on sale of properties for the quarter ending 2017-12-31 was $0.00.
- CONMED CORPORATION gain (loss) on sale of properties for the quarter ending 2016-12-31 was $0.00.
- CONMED CORPORATION gain (loss) on sale of properties for the quarter ending 2016-09-30 was $1.89M.
- CONMED CORPORATION gain (loss) on sale of properties for the quarter ending 2015-12-31 was $0.00.
- CONMED CORPORATION gain (loss) on sale of properties for fiscal 2018 was $0.00.
- CONMED CORPORATION gain (loss) on sale of properties for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- CONMED CORPORATION gain (loss) on sale of properties for fiscal 2016 was $1.89M.
- CONMED CORPORATION gain (loss) on sale of properties for fiscal 2015 was $0.00.
| Period end | Gain (Loss) on Sale of Properties 3 month | Gain (Loss) on Sale of Properties 6 month | Gain (Loss) on Sale of Properties 9 month | Gain (Loss) on Sale of Properties 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-02-25 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $0.00 10-K · filed 2019-02-25 | ||
| 2017-09-30 | $0.00 10-Q · filed 2017-11-02 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $1.89M derived: sum of 2 quarters · filed 2019-02-25 | $1.89M 10-K · filed 2019-02-25 | |
| 2016-09-30 | $1.89M 10-Q · filed 2017-11-02 | $1.89M 10-Q · filed 2017-11-02 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $0.00 10-K · filed 2018-02-26 | ||
| 2015-09-30 | $0.00 10-Q · filed 2016-10-28 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |